324 results
Page 9 of 17
8-K
EX-99.1
bmost9xhitwncz7y gz
5 Dec 11
Two Year Results of Phase 3 Studies with EYLEAâ„¢ (aflibercept) Injection in wet AMD Show Sustained Improvement in Visual Acuity
12:00am
8-K
EX-10.1
1enk29vx42kl48
24 Oct 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.4
v68qri ecgxkb9alcwrx
24 Oct 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.7
fc54923
24 Oct 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.8
y858e5cl6s13
24 Oct 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
eyeev0dae
24 Oct 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.3
vi7w6o7
24 Oct 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.6
hy6gt p4x75n
24 Oct 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
1hp64j50ffumjdicimn
24 Oct 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.5
yv62vjj40twdm6f rv4
24 Oct 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
xs7udft2y6 8yqjbo
27 Apr 11
Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Second Phase 3 Study in Central Retinal Vein Occlusion
12:00am
8-K
EX-99.1
i4z4vv4qn y4b
20 Dec 10
Other Events
12:00am
8-K
EX-99.1
bjuqwfqguj3 eas
22 Nov 10
Bayer and Regeneron Report Positive Top-Line Results of Two Phase 3 Studies with VEGF Trap-Eye in Wet Age-related Macular Degeneration
12:00am